Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

NCT01370317 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MK-1029
DRUG: Placebo for MK-1029

Sponsor

Merck Sharp & Dohme LLC